PMC:3359311 / 1081-1393 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T529 9-10 . denotes .
T530 11-16 NNS denotes PBMCs
T531 17-21 IN denotes from
T532 22-24 NNP denotes CF
T533 25-33 NNS denotes patients
T534 34-37 CC denotes and
T535 38-46 NNS denotes controls
T536 47-56 VBD denotes displayed
T537 57-64 JJ denotes similar
T538 65-71 NNS denotes levels
T539 72-74 IN denotes of
T540 75-84 JJ denotes caspase-1
T541 85-95 NN denotes activation
T542 96-99 CC denotes and
T543 100-105 JJ denotes IL-1β
T544 106-116 NN denotes production
T545 117-121 WRB denotes when
T546 122-132 VBN denotes stimulated
T547 133-137 IN denotes with
T548 138-150 JJ denotes inflammasome
T549 151-161 NNS denotes activators
T550 161-162 . denotes .
T551 163-167 DT denotes This
T552 168-173 JJ denotes IL-1β
T553 174-184 NN denotes production
T554 185-188 VBD denotes was
T555 189-198 JJ denotes dependent
T556 199-201 IN denotes on
T557 202-207 JJ denotes NF-κB
T558 208-216 NN denotes activity
T559 217-220 CC denotes and
T560 221-226 MD denotes could
T561 227-229 VB denotes be
T562 230-238 VBN denotes enhanced
T563 239-241 IN denotes by
T564 242-249 VBG denotes priming
T565 250-254 IN denotes with
T566 255-258 NNP denotes LPS
T567 258-259 . denotes .
T568 260-267 RB denotes Finally
T569 267-268 , denotes ,
T570 269-277 NN denotes chemical
T571 278-288 NN denotes inhibition
T572 289-291 IN denotes of
T573 292-296 NNP denotes CFTR
T574 297-305 NN denotes activity
T575 306-308 IN denotes in
R468 T530 T536 nsubj PBMCs,displayed
R469 T531 T530 prep from,PBMCs
R470 T532 T533 compound CF,patients
R471 T533 T531 pobj patients,from
R472 T534 T533 cc and,patients
R473 T535 T533 conj controls,patients
R474 T536 T536 ROOT displayed,displayed
R475 T537 T538 amod similar,levels
R476 T538 T536 dobj levels,displayed
R477 T539 T538 prep of,levels
R478 T540 T541 amod caspase-1,activation
R479 T541 T539 pobj activation,of
R480 T542 T541 cc and,activation
R481 T543 T544 amod IL-1β,production
R482 T544 T541 conj production,activation
R483 T545 T546 advmod when,stimulated
R484 T546 T536 advcl stimulated,displayed
R485 T547 T546 prep with,stimulated
R486 T548 T549 amod inflammasome,activators
R487 T549 T547 pobj activators,with
R488 T550 T536 punct .,displayed
R489 T551 T553 det This,production
R490 T552 T553 compound IL-1β,production
R491 T553 T554 nsubj production,was
R492 T554 T554 ROOT was,was
R493 T555 T554 acomp dependent,was
R494 T556 T555 prep on,dependent
R495 T557 T558 amod NF-κB,activity
R496 T558 T556 pobj activity,on
R497 T559 T554 cc and,was
R498 T560 T562 aux could,enhanced
R499 T561 T562 auxpass be,enhanced
R500 T562 T554 conj enhanced,was
R501 T563 T562 prep by,enhanced
R502 T564 T563 pcomp priming,by
R503 T565 T564 prep with,priming
R504 T566 T565 pobj LPS,with
R505 T567 T554 punct .,was
R508 T570 T571 compound chemical,inhibition
R510 T572 T571 prep of,inhibition
R511 T573 T574 amod CFTR,activity
R512 T574 T572 pobj activity,of
R513 T575 T574 prep in,activity